Etripamil (Milestone Pharmaceuticals) for Paroxysmal Supraventricular Tachycardia

Etripamil is an investigational, self-administered, calcium-channel blocker, nasal spray for rapid termination of paroxysmal supraventricular tachycardia outside of the healthcare setting.